Combination of serum markers related to several mechanisms in Alzheimer's disease (Q44555806)

4 December 2017

title

Combination of serum markers related to several mechanisms in Alzheimer's disease (English)

1 reference

4 December 2017

0 references

1 reference

10

1 reference

4 December 2017

12

1 reference

4 December 2017

Teunissen CE

1

1 reference

4 December 2017

Lütjohann D

2

1 reference

4 December 2017

von Bergmann K

3

1 reference

4 December 2017

Verhey F

4

1 reference

4 December 2017

Vreeling F

5

1 reference

4 December 2017

Wauters A

6

1 reference

4 December 2017

Bosmans E

7

1 reference

4 December 2017

Bosma H

8

1 reference

4 December 2017

van Boxtel MP

9

1 reference

4 December 2017

Delanghe J

11

1 reference

4 December 2017

Verbeek MM

13

1 reference

4 December 2017

Rieckmann P

14

1 reference

4 December 2017

De Bruijn C

15

1 reference

4 December 2017

Steinbusch HW

16

1 reference

4 December 2017

de Vente J

17

1 reference

4 December 2017

publication date

1 November 2003

1 reference

4 December 2017

published in

Neurobiology of Aging

1 reference

4 December 2017

volume

24

1 reference

4 December 2017

issue

7

1 reference

4 December 2017

page(s)

893-902

1 reference

Dietary factors in Parkinson's disease: the role of food groups and specific foods

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Perivascular astrocytes within Alzheimer's disease plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Potent inhibition of both human interferon-gamma production and biologic activity by the Clara cell protein CC16

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

The human Clara cell protein: biochemical and biological characterisation of a natural immunosuppressor

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Neuroinflammation and Alzheimer disease: clinical and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

CSF tau and Abeta42: logical biomarkers for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Acute-phase proteins in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

George Lyman Duff Memorial Lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Diet and Parkinson's disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Cholesterol-lowering action of plant sterols

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Biological and clinical significance of haptoglobin polymorphism in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor rece

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Plant sterol and stanol margarines and health

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Total serum homocysteine in senile dementia of Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Telencephalin as an indicator for temporal-lobe dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Serum cholesterol, precursors and metabolites and cognitive performance in an aging population

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

p97 as a biomarker for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900005-8

7 January 2021

10.1016/S0197-4580(03)00005-8

Identifiers

DOI

1 reference

4 December 2017

1 reference